Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stemtech Canada is the Canadian operating entity of Stemtech, a public wellness and nutraceutical company focused on "stem cell nutrition" products sold through a direct selling model. The business markets plant-based dietary supplements and adjacent consumer health products intended to support release, circulation, and migration of the body’s own adult stem cells, along with oral care, skincare, and pet wellness offerings. Its core commercial products in Canada include stemrelease3, StemFlo, MigraStem, OraStem, and related consumer wellness products. The company appears to operate as a commercial sales and marketing subsidiary rather than a drug-development biotech, with no evident therapeutic pipeline in regulated clinical development. For a biotech analyst, this is best understood as a health-and-wellness/nutraceutical distribution business with stem-cell-themed branding rather than a traditional therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stemtech Canada.